首页|山甲白花汤联合吉西他滨抗胰腺癌耐药机制研究

山甲白花汤联合吉西他滨抗胰腺癌耐药机制研究

扫码查看
目的:探讨山甲白花汤联合吉西他滨抗胰腺癌耐药的作用机制.方法:将30只小鼠按随机数表法分为模型组、吉西他滨组和联合组,构建皮下移植瘤小鼠模型,分别使用山甲白花汤、吉西他滨及联合处理小鼠,观察肿瘤的体积、重量变化和类固醇受体辅激活因子/分化抑制蛋白1(Src/Id1)信号通路蛋白.将人胰腺癌细胞系1(PANC-1)细胞分为对照组、吉西他滨处理组、联合处理组、联合+微小核糖核酸-124-3p抑制剂(miR-124-3p inhibitor)组和联合+过表达信号转导蛋白2样1(oe-SDF2L1)组,比较各组细胞增殖与迁移能力、微核糖核酸-124-3p(miR-124-3p)、信号转导蛋白2样1(SDF2L1)及信使核糖核酸(mRNA)水平.结果:与吉西他滨组比较,联合组中肿瘤体积与重量降低、Id1和磷酸化非受体酪氨酸激酶/非受体酪氨酸激酶(p-Src/Src)、SDF2L1水平降低.与对照组比较,吉西他滨处理组细胞增殖与迁移率明显降低,微小核糖核酸-124-3p(miR-124-3p)水平升高且SDF2L1水平明显降低,与吉西他滨处理组比较,联合处理组细胞增殖与迁移率明显降低,miR-124-3p水平升高且SDF2L1水平明显降低,与联合处理组比较,联合+miR-124-3p inhibitor组和联合+oe-SDF2L1组细胞增殖与迁移率均明显升高,SDF2L1水平均明显升高.结论:山甲白花汤联合吉西他滨通过上调miR-124-3p抑制SDF2L1发挥抗胰腺癌耐药作用.
Drug Resistance Mechanism of Shanjia Baihua Decoction Combined with Gemcitabine Against Pancreatic Cancer
Objective:To explore the mechanism of Shanjia Baihua Decoction combined with gemcitabine in combating drug resist-ance in pancreatic cancer.Methods:Thirty mice were randomly divided into a model group,a gemcitabine group,and a combination group.A subcutaneous tumor transplantation model was established in mice.Mice were treated with Shanjia Baihua Decoction,gem-citabine,or Shanjia Baihua Decoction and gemcitabine in combination.Changes in tumor volume and weight were observed,along with the steroid receptor coactivator(Src)/inhibitor of differentiation(Id1)signaling pathway proteins.The human pancreatic canc-er cell line PANC-1 was divided into control,gemcitabine treatment,combination treatment,combination+miR-124-3p inhibitor,and combination+overexpressed SDF2L1 groups.Cell proliferation and migration abilities,as well as levels of miR-124-3p,SDF2L1,and mRNA were compared.Results:Compared to the gemcitabine group,the combination group exhibited reduced tumor volume and weight,and decreased levels of Id1 and p-Src/Src,and SDF2L1.Compared to the control group,the gemcitabine treat-ment group showed significantly reduced cell proliferation and migration rates,increased miR-124-3p levels,and decreased SDF2L1 levels.Compared to the gemcitabine treatment group,the combination group further reduced cell proliferation and migration rates,elevated miR-124-3p,and decreased SDF2L1 levels.Compared to the combination group,the combination+miR-124-3p inhibitor group and the combination+overexpressed SDF2L1 group showed significantly increased cell proliferation and migration rates,and elevated SDF2L1 levels.Conclusion:Shanjia Baihua Decoction combined with gemcitabine exerts its anti-drug resistance effect in pancreatic cancer by upregulating miR-124-3p to inhibit SDF2L1.

Shanjia Baihua DecoctionGemcitabinePancreatic cancerCell proliferationCell migrationSteroid receptor coac-tivatorInhibitor of differentiation 1Sterile alpha motif domain containing 2 like 1

孙素芹、樊蓉、叶婷、高磊、刘春婷、刘冬影、常丽、闫珺

展开 >

黑龙江中医药大学附属第二医院,哈尔滨,150001

黑龙江中医药大学附属第二医院哈南分院,哈尔滨,150060

哈尔滨市胸科医院,哈尔滨,150056

黑龙江中医药大学附属第一医院,哈尔滨,150000

展开 >

山甲白花汤 吉西他滨 胰腺癌 细胞增殖 细胞迁移 类固醇受体辅激活因子 分化抑制蛋白1 信号转导蛋白2样1

2024

世界中医药
世界中医药学会联合会

世界中医药

CSTPCDCHSSCD北大核心
影响因子:1.266
ISSN:1673-7202
年,卷(期):2024.19(17)